Wide-range C-reactive protein efficacy in acute ischemic stroke patients

Acta Neurologica Scandinavica

Volumn 114, Issue 1, 2006, Pages 29-32

  Shenhar Tsarfaty, S ^b   Ben Assayag, E ^b   Bova, I ^b   Vered, Y ^b   Berliner, S ^a,b   Rogowski, O ^b   Shapira, I ^b   Bornstein, N M ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Stroke; Transient ischemic attack; Wide range C reactive protein

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; SEDIMENTATION RATE; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; VENOUS BLOOD;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CEREBROVASCULAR ACCIDENT; FEMALE; FIBRINOGEN; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 33745038976     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2005.00572.x     Document Type: Article

References (28)

1. Libby P Ridker PM Maseri A. Inflammation and atherosclerosis. Circulation 2002 105 : 1135 43.
2. Ridker PM. On evolutionary biology, inflammation, infection, and the causes of atherosclerosis. Circulation 2002 105 : 2 4.
3. Viles-Gonzalez JF Fuster V Badimon JJ. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J 2004 25 : 1197 207.
4. Ridker PM. Cardiology patient page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation 2003 108 : e81 5.
5. Biasucci LM. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper. Circulation 2004 110 : e560 7.
6. Silvestri A Vitale C Ferretti F Onorati D Fini M Rosano GM. Plasma levels of inflammatory C-reactive protein and interleukin-6 predict outcome in elderly patients with stroke. J Am Geriatr Soc 2004 52 : 1586 7.
7. Audebert HJ Rott MM Eck T Haberl RL. Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke 2004 35 : 2128 33.
8. Bassuk SS Rifai N Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 2004 29 : 439 93.
9. Ridker PM Cannon CP Morrow D et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005 352 : 20 8.
10. International Committee for Standardization in Hematology. Recommendation of measurement of erythrocyte sedimentation rate of human blood. Immunochemistry 1965 2 : 235 54.
11. Clauss A. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens. Acta Haematol Basel 1957 17 : 237 46.
12. Rifai N Tracy RP Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999 45 : 2136 41.
13. Rogowski O Vered Y Shapira I Hirsh M Zakut V Berliner S. Introducing the wide range C-reactive protein (wr-CRP) into clinical use for the detection of microinflammation. Clin Chim Acta 2005 358 : 151 58.
14. Ridker PM. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am Heart J 2004 148 : S19 26.
15. Audebert HJ Pellkofer TS Wimmer ML Haberl RL. Progression in lacunar stroke is related to elevated acute phase parameters. Eur Neurol 2004 51 : 125 31.
16. Chamorro A. Role of inflammation in stroke and atherothrombosis. Cerebrovasc Dis 2004 17 Suppl. 3 1 5.
17. Intiso D Zarrelli MM Lagioia G et al. Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients. Neurol Sci 2004 24 : 390 6.
18. Smith CJ Emsley HC Gavin CM et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 2004 4 : 2.
19. Di Napoli M Papa F. Association between blood pressure and C-reactive protein levels in acute ischemic stroke. Hypertension 2003 42 : 1117 23.
20. Lindsberg PJ Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke 2003 34 : 2518 32.
21. Arenillas JF Alvarez-Sabin J Molina CA et al. C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 2003 34 : 2463 8.
22. Cao JJ Thach C Manolio TA et al. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the cardiovascular health study. Circulation 2003 108 : 166 70.
23. Curb JD Abbott RD Rodriguez BL et al. C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 2003 107 : 2016 20.
24. Di Napoli M Papa F. C-reactive protein and blood pressure in the acute phase after an ischemic stroke. Stroke 2003 34 : 839.
25. Winbeck K Poppert H Etgen T Conrad B Sander D. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 2002 33 : 2459 64.
26. Waje-Andreassen U Krakenes J Ulvestad E et al. IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol Scand 2005 111 : 360 5.
27. Labarrere CA Zaloga GP. C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis. Am J Med 2004 117 : 499 507.
28. Jialal I Devaraj S Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis Hypertension 2004 44 : 6 11.